Conboy, C. B., Yonkus, J. A., Buckarma, E. H., Mun, D. G., Werneburg, N. W., Watkins, R. D., Alva-Ruiz, R., Tomlinson, J. L., Guo, Y., Wang, J., O’Brien, D., McCabe, C. E., Jessen, E., Graham, R. P., Buijsman, R. C., Vu, D., de Man, J., Ilyas, S. I., Truty, M. J., Borad, M., Pandey, A., Gores, G. J., Smoot, R. L. (2022). LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma. Journal of Hepatology. S0168-8278(22)03121-X. [PubMed]